Panel Discussion: Potency Assay Development Over the Development Lifecycle

Time: 4:30 pm
day: Conference Day One - PM


• Should we start potency assay development early? Or should we wait until clearer signals emerge later in subsequent phases 

that a therapy is likely to be safe and efficacious? 

• How do we translate early phase potency assays into late phase assays? 

• At what stage do you begin to qualify and validate?